Search clinical trials for: Combined ABMT and CBT

Total 5469 results

National Cancer Institute (NCI)

Completed

Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Breast Carcinoma | Ovarian Carcinoma | Pancreatic Carcinoma | Prostate Carcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative... and other conditions

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment

Recurrent Neuroblastoma | Disseminated Neuroblastoma

United States, Canada
University of Oviedo
European Regional Development Fund; Ministerio de Ciencia e Innovación, Spain; Spanish State Research Agency

Completed

Smoking Cessation Treatment for Smokers With Obesity

Tobacco Use Disorder

Spain
University of Miami
University of Minnesota

Completed

Culturally Specific Interventions: African American Smokers (SB2)

Smoking | Smoking Cessation

United States
Abbott

Completed

Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.

Dyslipidemia | Coronary Heart Disease | Mixed Dyslipidemia

United States
Imperial College London

Completed

Mechanisms and Innovations in Cardiac Resynchronisation Therapy (MIC)

Heart Failure | Left Bundle-Branch Block | Left Ventricular Systolic Dysfunction | Right Bundle-Branch Block | Non-Specific Intraventricular Conduction Defect

United Kingdom
Abbott
Statistika Consultoria Ltda

Completed

Efficacy and Safety of the Use of Venocur Triplex® in Patients With Chronic Venous Insufficiency

Venous Insufficiency

Brazil
AbbVie (prior sponsor, Abbott)

Completed

A Randomized Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072 (Champion2)

Hepatitis C | Chronic Hepatitis C Infection | HCV | Hepatitis C Genotype 1

United States, Puerto Rico
AbbVie

Completed

Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease

Hepatitis C Virus (HCV)
University of Copenhagen
University of Exeter; The University of Western Australia

Completed

Rumination Focused Cognitive Behavioral Therapy for Major Depression and Recurrent Depression (RuCoD)

Depression | Recurrent Depression

Denmark
AbbVie (prior sponsor, Abbott)

Completed

A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies

Follicular Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Peripheral T-cell Lymphoma | Lymphoid Malignancies | Chronic Lymphoid Leukemia

United States, Canada
AbbVie (prior sponsor, Abbott)

Completed

A Crossover Study of the Safety and Tolerability of Two Formulations of Adalimumab

Rheumatoid Arthritis

Australia, Canada, Germany
AbbVie (prior sponsor, Abbott)

Completed

Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis

Psoriasis

Mexico
Abbott
Eisai Co., Ltd.; Abbott Japan Co.,Ltd

Completed

Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
AbbVie

Available

Expanded Access to Venetoclax

Multiple Myeloma | Non-Hodgkin's Lymphoma | Amyloidosis | Chronic Lymphocytic Leukemia (CLL) | Acute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | Plasma Cell Leukemia
AbbVie

Completed

Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms (CisCP)

Chronic Pancreatitis

United States
Fondazione Italiana Linfomi - ETS

Terminated

Use of Venetoclax as Single Agent in Patients With Relapsed/Refractory BCL-2 Positive Peripheral T Cell Lymphoma

T-Cell Lymphoma Relapsed | T-Cell Lymphoma Refractory

Italy
AbbVie

Completed

Study to Assess Adverse Events and Compare How Crushed, Ground, and Intact Oral Tablets Venetoclax Moves Through the Body of Healthy Female Adult Volunteers

Healthy Volunteers

United States
Peter MacCallum Cancer Centre, Australia

Active, not recruiting

ABT-199 & Ibrutinib in Mantle Cell Lymphoma (AIM) (AIM)

Mantle Cell Lymphoma

Australia
AbbVie

Completed

A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent). (VENICE II)

Chronic Lymphocytic Leukemia (CLL)

Argentina, Australia, Bulgaria, Hong Kong, Hungary, Mexico, New Zealand, Poland, Russian Federation, Taiwan
AbbVie

Withdrawn

Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic Cancer

Exocrine Pancreatic Insufficiency (EPI)
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Counseling for Primary Care Office-based Buprenorphine

Opiate Dependence

United States
University of Oviedo

Completed

Smoking Cessation Treatment for Depressed Smokers

Tobacco Use Disorder

Spain
Norwegian School of Sport Sciences
University of Tromso; The Norwegian Women´s Public Health Association

Completed

Treatment of Eating Disorders by Physical Activity and Nutrition Counseling (FAKT)

Bulimia Nervosa | Binge Eating Disorder

Norway
M.D. Anderson Cancer Center

Recruiting

Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-ALL or T-LBL

Leukemia | Leukemia, Lymphoblastic

United States
AbbVie

Active, not recruiting

A Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Participants With Myelofibrosis (REFINE)

Myelofibrosis (MF)

United States, Australia, Canada, Croatia, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Puerto Rico, Spain, United Kingdom, Taiwan
AbbVie
Genentech, Inc.

Completed

Assess the Oral Bioavailability of a New ABT-263 Formulation in Subjects With Cancer

Solid Tumors | Lymphoid Malignancy
Rhode Island Hospital
Stanford University; University of Cincinnati; American Epilepsy Society; Epilepsy...

Completed

Treatment Trial for Psychogenic Nonepileptic Seizures (NEST-T_1)

Depression | Stress Disorders, Post-Traumatic | Dissociative Disorders | Conversion Disorder | Convulsion, Non-Epileptic

United States
Ohio State University Comprehensive Cancer Center

Active, not recruiting

Venetoclax and Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations

Chronic Lymphocytic Leukemia | Ibrutinib Resistance

United States
AstraZeneca

Completed

Interaction Between ABT-335, Rosuvastatin and Warfarin

Healthy

United States
Brown University
National Institute of Mental Health (NIMH)

Completed

Integrated Treatment for Comorbid Depression and Obesity in Adolescents

Depression | Overweight

United States
AstraZeneca

Completed

Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Capsules Relative to That From Co-administration of ABT-335 and Rosuvastatin for the 5/45mg Dosage Form.

Adverse Events | Pharmacokinetic Variables

United States
University of Alabama at Birmingham

Withdrawn

Imaging With [89Zr]Panitumumab-PET/MRI in Patients With Newly Diagnosed Colorectal Cancer (Panitumumab)

Metastatic Colon Cancer

United States
AbbVie

Completed

A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis (VISUAL III)

Uveitis
AbbVie (prior sponsor, Abbott)

Completed

Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis

Ulcerative Colitis
AbbVie

Completed

Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis (AS) Patients (AS PMOS)

Ankylosing Spondylitis
AbbVie (prior sponsor, Abbott)

Completed

A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting (InspirAda)

Ulcerative Colitis
Abbott
Eisai Co., Ltd.

Completed

A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis

Ankylosing Spondylitis

Japan
Abbott

Completed

Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease

Crohn's Disease

United States, Belgium, Canada, Czech Republic, France, Netherlands, Poland, United Kingdom
Abbott

Completed

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

Psoriasis

United States, Canada
Abbott
Eisai Co., Ltd.; Abbott Japan Co.,Ltd

Completed

Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Abbott

Approved for marketing

Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis (ReAct)

Rheumatoid Arthritis
Martine Puts
University Health Network, Toronto; Sunnybrook Health Sciences Centre

Recruiting

The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support Person (SOAR)

Lung Cancer | Gastro-intestinal Cancer | Genito-Urinary Cancer

Canada
AbbVie (prior sponsor, Abbott)

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-333 Alone and in Combination With Pegylated Interferon (pegIFN) and Ribavirin (RBV) in Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Chronic Hepatitis C Virus Infection

United States, Puerto Rico
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Trabectedin and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Resistant or Intolerant to a BTK Inhibitor

Refractory Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic Lymphoma

United States
AbbVie

Terminated

Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With Myelofibrosis

Myelofibrosis (MF)

United States, Korea, Republic of, South Africa
AbbVie
Genentech, Inc.

Completed

An Extension Study of ABT-199 in Subjects With Advanced Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

United States
University Hospital Tuebingen

Unknown

Early Antibiotic Therapy and Vaccination

Vaccination Reaction

Germany
University of South Florida
National Institute of Mental Health (NIMH)

Completed

A Mobile Health Solution for Homework During CBT

Depression | Anxiety | Posttraumatic Stress Disorder

United States
Groupe Francophone des Myelodysplasies
Bristol-Myers Squibb; AbbVie

Recruiting

Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes

Untreated Myelodysplastic Syndrome

France

Search clinical trials for: Combined ABMT and CBT

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations